Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
| Aktionär | Typ | Gehalten (Tatsächlich) | % Ausstehender Aktien | Marktwert | Positionsdatum |
|---|---|---|---|---|---|
| Acuta Capital Partners, LLC | Institution | 4.685.912 | 9,48% | US$ 19,21M | 2026-05-14 |
| QVT Financial LP | Institution | 4.615.709 | 9,33% | US$ 18,92M | 2026-03-31 |
| OrbiMed Advisors LLC | Institution | 4.166.000 | 8,42% | US$ 17,08M | 2026-03-31 |
| Suvretta Capital Management, LLC | Institution | 3.700.000 | 7,48% | US$ 15,17M | 2026-03-31 |
| Longwood Capital, LP | Institution | 3.538.288 | 7,15% | US$ 14,51M | 2026-05-14 |
| Avoro Capital Advisors LLC | Institution | 3.471.752 | 7,02% | US$ 14,23M | 2026-05-12 |
| Ally Bridge Group | Institution | 2.887.939 | 5,84% | US$ 11,84M | 2026-03-31 |
| Coastlands Capital LP | Institution | 2.819.215 | 5,70% | US$ 11,56M | 2026-04-17 |
| Coastlands Capital Partners LP | Institution | 2.819.215 | 5,70% | US$ 11,56M | 2025-08-19 |
| KVP Capital, LP | Institution | 2.165.998 | 4,38% | US$ 8,88M | 2026-05-14 |
| Kvp Capital Advisors, LP | Institution | 2.165.998 | 4,38% | US$ 8,88M | 2026-05-14 |
| Artal Group S.A. | Institution | 2.082.000 | 4,21% | US$ 8,54M | 2026-03-31 |
| BML Investment Partners, L.P. | Institution | 1.971.137 | 3,99% | US$ 8,08M | 2025-03-05 |
| Dr. Neil Desai | Insider | 1.811.241 | 3,66% | US$ 7,43M | 2026-04-17 |
| Vanguard Capital Management, LLC | Institution | 1.315.770 | 2,66% | US$ 5,39M | 2026-03-31 |
| Dr. Baiteng Zhao | Insider | 1.250.000 | 2,53% | US$ 5,13M | 2026-04-17 |
| Acuta Opportunity Fund, LP | Institution | 1.147.624 | 2,32% | US$ 4,71M | 2026-05-14 |
| Acorn Bioventures | Institution | 1.139.363 | 2,30% | US$ 4,67M | 2026-03-31 |
| StemPoint Capital LP | Institution | 939.369 | 1,90% | US$ 3,85M | 2026-03-31 |
| Ally Bridge MedAlpha Master Fund L.P. | Institution | 817.939 | 1,65% | US$ 3,35M | 2025-03-04 |
| Avoro Ventures Fund L.P. | Institution | 622.350 | 1,26% | US$ 2,55M | 2025-02-28 |
| Dr. David Lennon | Insider | 569.643 | 1,15% | US$ 2,34M | 2026-05-14 |
| Balyasny Asset Management L.P. | Institution | 550.441 | 1,11% | US$ 2,26M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 457.540 | 0,93% | US$ 1,88M | 2026-03-31 |
| Mr. Bryan Ball | Insider | 448.126 | 0,91% | US$ 1,84M | 2026-05-14 |
| Renaissance Technologies LLC | Institution | 428.622 | 0,87% | US$ 1,76M | 2026-03-31 |
| BlackRock, Inc. | Institution | 351.385 | 0,71% | US$ 1,44M | 2026-03-31 |
| Mr. Braden Leonard | Insider | 335.000 | 0,68% | US$ 1,37M | 2025-03-05 |
| Mr. Scott Giacobello | Insider | 333.489 | 0,67% | US$ 1,37M | 2026-05-14 |
| Ecor1 Capital Fund Qualified, L.P. | Institution | 324.365 | 0,66% | US$ 1,33M | 2024-12-31 |
| Millennium Management LLC | Institution | 309.674 | 0,63% | US$ 1,27M | 2026-03-31 |
| Eversept Partners, L.P. | Institution | 306.800 | 0,62% | US$ 1,26M | 2026-03-31 |
| Woodline Partners LP | Institution | 281.497 | 0,57% | US$ 1,15M | 2026-03-31 |
| Mr. Caley Castelein | Insider | 274.796 | 0,56% | US$ 1,13M | 2026-05-14 |
| Two Sigma Investments, LP | Institution | 273.482 | 0,55% | US$ 1,12M | 2026-03-31 |
| Bridgeway Capital Management, LLC | Institution | 215.284 | 0,44% | US$ 882,66k | 2026-03-31 |
| Vanguard Fiduciary Trust Company | Institution | 214.827 | 0,43% | US$ 880,79k | 2026-03-31 |
| Susquehanna International Group, LLP | Institution | 203.465 | 0,41% | US$ 834,21k | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 160.382 | 0,32% | US$ 657,57k | 2026-03-31 |
| Jane Street Group, LLC | Institution | 151.110 | 0,31% | US$ 619,55k | 2026-03-31 |
| ADAR1 Capital Management, LLC | Institution | 128.503 | 0,26% | US$ 526,86k | 2026-03-31 |
| Verdad Advisers, L.P. | Institution | 115.484 | 0,23% | US$ 473,48k | 2026-03-31 |
| Northern Trust Global Investments | Institution | 107.266 | 0,22% | US$ 439,79k | 2026-03-31 |
| Citadel Advisors LLC | Institution | 91.852 | 0,19% | US$ 376,59k | 2026-03-31 |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
